Triple
T22690161
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | CYP1A2 |
E561029
|
entity |
| Predicate | substrateOf |
P37222
|
FINISHED |
| Object | theophylline |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: theophylline | Statement: [CYP1A2, substrateOf, theophylline]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: theophylline Context triple: [CYP1A2, substrateOf, theophylline]
-
A.
Docefrez
Docefrez is a branded formulation of the chemotherapy drug docetaxel used to treat various cancers, including breast, lung, and prostate cancer.
-
B.
Fenodyree
Fenodyree is a mythical, goblin-like creature from Alan Garner’s fantasy novel "The Weirdstone of Brisingamen," known for aiding the protagonists with its otherworldly powers and knowledge of the hidden realms.
-
C.
Comethazine
Comethazine is an American rapper and songwriter known for his aggressive trap style and viral hits like "Walk" and "Bands."
-
D.
dextromethorphan
Dextromethorphan is a common over-the-counter antitussive (cough suppressant) that acts on the central nervous system and is also known for its potential for misuse at high doses.
-
E.
Brilique
Brilique is a brand name for the antiplatelet medication ticagrelor, used to reduce the risk of cardiovascular events such as heart attacks and strokes in patients with acute coronary syndromes or a history of myocardial infarction.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: theophylline Target entity description: Theophylline is a methylxanthine drug used primarily as a bronchodilator in the treatment of asthma and chronic obstructive pulmonary disease.
-
A.
Docefrez
Docefrez is a branded formulation of the chemotherapy drug docetaxel used to treat various cancers, including breast, lung, and prostate cancer.
-
B.
Fenodyree
Fenodyree is a mythical, goblin-like creature from Alan Garner’s fantasy novel "The Weirdstone of Brisingamen," known for aiding the protagonists with its otherworldly powers and knowledge of the hidden realms.
-
C.
Comethazine
Comethazine is an American rapper and songwriter known for his aggressive trap style and viral hits like "Walk" and "Bands."
-
D.
dextromethorphan
Dextromethorphan is a common over-the-counter antitussive (cough suppressant) that acts on the central nervous system and is also known for its potential for misuse at high doses.
-
E.
Brilique
Brilique is a brand name for the antiplatelet medication ticagrelor, used to reduce the risk of cardiovascular events such as heart attacks and strokes in patients with acute coronary syndromes or a history of myocardial infarction.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e2454d71b48190a1f80af9f82b6fcf |
completed | April 17, 2026, 2:35 p.m. |
| NER | Named-entity recognition | batch_69f1789a1fd08190bce5fa0babe695d3 |
completed | April 29, 2026, 3:18 a.m. |
Created at: April 17, 2026, 3:13 p.m.